Fresh or frozen day 6 blastocyst transfer: is there still a question?


Journal

Reproductive biology and endocrinology : RB&E
ISSN: 1477-7827
Titre abrégé: Reprod Biol Endocrinol
Pays: England
ID NLM: 101153627

Informations de publication

Date de publication:
24 Apr 2024
Historique:
received: 23 01 2024
accepted: 27 03 2024
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 24 4 2024
Statut: epublish

Résumé

The Live Birth Rate (LBR) after day 5 (D5) blastocyst transfer is significantly higher than that with D6 embryos in both fresh and frozen-vitrified embryo transfer cycles, according to the most recently published meta-analyses. Therefore, for women obtaining only D6 blastocysts, the chances of pregnancy may be lower but nonetheless sufficient to warrant transferring such embryos. The best strategy for transfer (i.e., in fresh versus frozen cycles) remains unclear and there is a paucity of data on this subject. A total of 896 couples with D6 single blastocyst transfers were retrospectively analyzed: patients receiving a fresh D6 embryo transfer (Fresh D6 transfer group, n = 109) versus those receiving a frozen-thawed D6 embryo transfer (Frozen D6 transfer group, n = 787). A subgroup comprising a freeze-all cycle without any previous fresh or frozen D5 embryo transfers (Elective frozen D6, n = 77) was considered and also compared with the Fresh D6 transfer group. We compared LBR between these two groups. Correlation between D6 blastocyst morphology according to Gardner's classification and live birth occurrence was also evaluated. Statistical analysis was carried out using univariate and multivariate logistic regression models. The LBR was significantly lower after a fresh D6 blastocyst transfer compared to the LBR with a frozen-thawed D6 blastocyst transfer [5.5% (6/109) vs. 12.5% (98/787), p = 0.034]. Comparison between LBR after Elective frozen D6 group to the Fresh D6 blastocyst transfers confirmed the superiority of frozen D6 blastocyst transfers. Statistical analysis of the blastocyst morphology parameters showed that both trophectoderm (TE) and inner cell mass (ICM) grades were significantly associated with the LBR after D6 embryo transfer (p < 0.001, p = 0.037). Multiple logistic regression revealed that frozen D6 thawed transfer was independently associated with a higher LBR compared with fresh D6 transfer (OR = 2.54; 95% CI: [1.05-6.17]; p = 0.038). Our results also show that transferring a good or top-quality D6 blastocyst increased the chances of a live birth by more than threefold. Our results indicate that transferring D6 blastocysts in frozen cycles improves the LBR, making it the best embryo transfer strategy for these slow-growing embryos. Not applicable.

Sections du résumé

BACKGROUND BACKGROUND
The Live Birth Rate (LBR) after day 5 (D5) blastocyst transfer is significantly higher than that with D6 embryos in both fresh and frozen-vitrified embryo transfer cycles, according to the most recently published meta-analyses. Therefore, for women obtaining only D6 blastocysts, the chances of pregnancy may be lower but nonetheless sufficient to warrant transferring such embryos. The best strategy for transfer (i.e., in fresh versus frozen cycles) remains unclear and there is a paucity of data on this subject.
METHODS METHODS
A total of 896 couples with D6 single blastocyst transfers were retrospectively analyzed: patients receiving a fresh D6 embryo transfer (Fresh D6 transfer group, n = 109) versus those receiving a frozen-thawed D6 embryo transfer (Frozen D6 transfer group, n = 787). A subgroup comprising a freeze-all cycle without any previous fresh or frozen D5 embryo transfers (Elective frozen D6, n = 77) was considered and also compared with the Fresh D6 transfer group. We compared LBR between these two groups. Correlation between D6 blastocyst morphology according to Gardner's classification and live birth occurrence was also evaluated. Statistical analysis was carried out using univariate and multivariate logistic regression models.
RESULTS RESULTS
The LBR was significantly lower after a fresh D6 blastocyst transfer compared to the LBR with a frozen-thawed D6 blastocyst transfer [5.5% (6/109) vs. 12.5% (98/787), p = 0.034]. Comparison between LBR after Elective frozen D6 group to the Fresh D6 blastocyst transfers confirmed the superiority of frozen D6 blastocyst transfers. Statistical analysis of the blastocyst morphology parameters showed that both trophectoderm (TE) and inner cell mass (ICM) grades were significantly associated with the LBR after D6 embryo transfer (p < 0.001, p = 0.037). Multiple logistic regression revealed that frozen D6 thawed transfer was independently associated with a higher LBR compared with fresh D6 transfer (OR = 2.54; 95% CI: [1.05-6.17]; p = 0.038). Our results also show that transferring a good or top-quality D6 blastocyst increased the chances of a live birth by more than threefold.
CONCLUSIONS CONCLUSIONS
Our results indicate that transferring D6 blastocysts in frozen cycles improves the LBR, making it the best embryo transfer strategy for these slow-growing embryos.
CLINICAL TRIAL NUMBER BACKGROUND
Not applicable.

Identifiants

pubmed: 38659014
doi: 10.1186/s12958-024-01214-w
pii: 10.1186/s12958-024-01214-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-21-CE014-0085-21

Informations de copyright

© 2024. The Author(s).

Références

Cutting R. Single embryo transfer for all. Best Pract Res Clin Obstet Gynaecol. 2018;53:30–7.
doi: 10.1016/j.bpobgyn.2018.07.001
Bourdon M, Pocate-Cheriet K, Finet de Bantel A, Grzegorczyk-Martin V, Amar Hoffet A, Arbo E, et al. Day 5 versus day 6 blastocyst transfers: a systematic review and meta-analysis of clinical outcomes. Hum Reprod. 2019;34(10):1948–64.
doi: 10.1093/humrep/dez163 pubmed: 31644803 pmcid: 7967799
Kaing A, Kroener LL, Tassin R, Li M, Liu L, Buyalos R, et al. Earlier day of blastocyst development is predictive of embryonic euploidy across all ages: essential data for physician decision-making and counseling patients. J Assist Reprod Genet. 2018;35(1):119–25.
doi: 10.1007/s10815-017-1038-8 pubmed: 28894983
Taylor TH, Patrick JL, Gitlin SA, Wilson JM, Crain JL, Griffin DK. Comparison of aneuploidy, pregnancy and live birth rates between day 5 and day 6 blastocysts. Reprod Biomed Online. 2014;29(3):305–10.
doi: 10.1016/j.rbmo.2014.06.001 pubmed: 25043891
Irani M, O’Neill C, Palermo GD, Xu K, Zhang C, Qin X, et al. Blastocyst development rate influences implantation and live birth rates of similarly graded euploid blastocysts. Fertil Steril. 2018;110(1):95–e1021.
doi: 10.1016/j.fertnstert.2018.03.032 pubmed: 29908774
Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R. Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony. Fertil Steril. 2008;89(1):20–6.
doi: 10.1016/j.fertnstert.2006.08.092 pubmed: 17224151
Loubersac S, Inquel A, Lefebvre T, Lammers J, Barriere P, Freour T, et al. What is the best strategy for slowly developing blastocysts? J Gynecol Obstet Hum Reprod. 2022;51(7):102414.
doi: 10.1016/j.jogoh.2022.102414 pubmed: 35640804
Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65–76.
doi: 10.1001/jama.2021.4788 pubmed: 34228062 pmcid: 9302705
Bourdon M, Santulli P, Maignien C, Gayet V, Pocate-Cheriet K, Marcellin L, et al. The deferred embryo transfer strategy improves cumulative pregnancy rates in endometriosis-related infertility: a retrospective matched cohort study. PLoS ONE. 2018;13(4):e0194800.
doi: 10.1371/journal.pone.0194800 pubmed: 29630610 pmcid: 5890985
Gardner DK, Schoolcraft WB, Wagley L, Schlenker T, Stevens J, Hesla J. A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization. Hum Reprod. 1998;13(12):3434–40.
doi: 10.1093/humrep/13.12.3434 pubmed: 9886530
Maignien C, Bourdon M, Marcellin L, Laguillier-Morizot C, Borderie D, Chargui A, et al. Low serum progesterone affects live birth rate in cryopreserved blastocyst transfer cycles using hormone replacement therapy. Reprod Biomed Online. 2022;44(3):469–77.
doi: 10.1016/j.rbmo.2021.11.007 pubmed: 34980570
Chen Z-J, Legro RS. Fresh versus frozen embryos in polycystic ovary syndrome. N Engl J Med. 2016;375(20):e42.
doi: 10.1056/NEJMc1611871 pubmed: 27959602
Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The International Glossary on Infertility and Fertility Care, 2017. Hum Reprod. 2017;32(9):1786–801.
doi: 10.1093/humrep/dex234 pubmed: 29117321 pmcid: 5850297
Kolte AM, Bernardi LA, Christiansen OB, Quenby S, Farquharson RG, Goddijn M, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015;30(3):495–8.
doi: 10.1093/humrep/deu299 pubmed: 25376455
Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C. Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer. Fertil Steril. 2014;102(1):3–9.
doi: 10.1016/j.fertnstert.2014.04.018 pubmed: 24842675
Murata Y, Oku H, Morimoto Y, Tokuda M, Murata T, Sugihara K, et al. Freeze-thaw programmes rescue the implantation of day 6 blastocysts. Reprod Biomed Online. 2005;11(4):428–33.
doi: 10.1016/S1472-6483(10)61134-0 pubmed: 16274600
Yamamoto S, Umeki M, Hamano T, Matsusita F, Kuwahara K. Elective cryopreservation of all day 5 blastocysts is more effective than using day 6 blastocysts for improving pregnancy outcome in stimulated cycles. Reprod Med Biol. 2008;7(2):75–83.
doi: 10.1111/j.1447-0578.2008.00203.x pubmed: 29662418 pmcid: 5891804
Shapiro BS, Daneshmand ST, Restrepo H, Garner FC, Aguirre M, Hudson C. Matched-cohort comparison of single-embryo transfers in fresh and frozen-thawed embryo transfer cycles. Fertil Steril. 2013;99(2):389–92.
doi: 10.1016/j.fertnstert.2012.09.044 pubmed: 23062733
Ahlström A, Westin C, Reismer E, Wikland M, Hardarson T. Trophectoderm morphology: an important parameter for predicting live birth after single blastocyst transfer. Hum Reprod. 2011;26(12):3289–96.
doi: 10.1093/humrep/der325 pubmed: 21972253
Hill MJ, Richter KS, Heitmann RJ, Graham JR, Tucker MJ, DeCherney AH, et al. Trophectoderm grade predicts outcomes of single-blastocyst transfers. Fertil Steril. 2013;99(5):1283–e12891.
doi: 10.1016/j.fertnstert.2012.12.003 pubmed: 23312233
Ozgur K, Berkkanoglu M, Bulut H, Donmez L, Isikli A, Coetzee K. Blastocyst age, expansion, trophectoderm morphology, and number cryopreserved are variables predicting clinical implantation in single blastocyst frozen embryo transfers in freeze-only-IVF. J Assist Reprod Genet. 2021;38(5):1077–87.
doi: 10.1007/s10815-021-02110-7 pubmed: 33594625 pmcid: 8190197
Van den Abbeel E, Balaban B, Ziebe S, Lundin K, Cuesta MJG, Klein BM, et al. Association between blastocyst morphology and outcome of single-blastocyst transfer. Reprod Biomed Online. 2013;27(4):353–61.
doi: 10.1016/j.rbmo.2013.07.006 pubmed: 23953585
Abdala A, Elkhatib I, Bayram A, Arnanz A, El-Damen A, Melado L, et al. Day 5 vs day 6 single euploid blastocyst frozen embryo transfers: which variables do have an impact on the clinical pregnancy rates? J Assist Reprod Genet. 2022;39(2):379–88.
doi: 10.1007/s10815-021-02380-1 pubmed: 35064434 pmcid: 8956773
Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G, et al. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Hum Reprod. 2014;29(6):1173–81.
doi: 10.1093/humrep/deu033 pubmed: 24578475
Haas J, Meriano J, Bassil R, Barzilay E, Zilberberg E, Casper RF. Developmental potential of slow-developing embryos: day-5 morulae compared with day-5 cavitating morulae. Fertil Steril. 2019;111(1):105–11.
doi: 10.1016/j.fertnstert.2018.08.053 pubmed: 30442415
Tannus S, Cohen Y, Henderson S, Al Ma’mari N, Shavit T, Son W-Y, et al. Fresh transfer of Day 5 slow-growing embryos versus deferred transfer of vitrified, fully expanded Day 6 blastocysts: which is the optimal approach? Hum Reprod. 2019;34(1):44–51.
doi: 10.1093/humrep/dey351 pubmed: 30517719

Auteurs

Lucile Ferreux (L)

Hôpitaux de Paris (AP- HP), APHP, Centre - Université de Paris Cité, Hôpital Cochin, Service de Biologie de la Reproduction-CECOS, Paris, France. lucile.ferreux@aphp.fr.
Université de Paris Cité, Institut Cochin, U1016, INSERM, CNRS, Paris, F-75014, France. lucile.ferreux@aphp.fr.

Mathilde Bourdon (M)

Hôpitaux de Paris (AP-HP), AP-HP, Centre-, Université de Paris Cité, Hôpital Cochin, Service de Gynécologie-Obstétrique II et de Médecine de la Reproduction, Paris, France.
Université de Paris Cité, Institut Cochin, U1016, INSERM, CNRS, Paris, F-75014, France.

Ahmed Chargui (A)

Hôpitaux de Paris (AP- HP), APHP, Centre - Université de Paris Cité, Hôpital Cochin, Service de Biologie de la Reproduction-CECOS, Paris, France.

Julie Firmin (J)

Hôpitaux de Paris (AP- HP), APHP, Centre - Université de Paris Cité, Hôpital Cochin, Service de Biologie de la Reproduction-CECOS, Paris, France.

Chloé Maignien (C)

Hôpitaux de Paris (AP-HP), AP-HP, Centre-, Université de Paris Cité, Hôpital Cochin, Service de Gynécologie-Obstétrique II et de Médecine de la Reproduction, Paris, France.

Pietro Santulli (P)

Hôpitaux de Paris (AP-HP), AP-HP, Centre-, Université de Paris Cité, Hôpital Cochin, Service de Gynécologie-Obstétrique II et de Médecine de la Reproduction, Paris, France.
Université de Paris Cité, Institut Cochin, U1016, INSERM, CNRS, Paris, F-75014, France.

Catherine Patrat (C)

Hôpitaux de Paris (AP- HP), APHP, Centre - Université de Paris Cité, Hôpital Cochin, Service de Biologie de la Reproduction-CECOS, Paris, France.
Université de Paris Cité, Institut Cochin, U1016, INSERM, CNRS, Paris, F-75014, France.

Khaled Pocate-Cheriet (K)

Hôpitaux de Paris (AP- HP), APHP, Centre - Université de Paris Cité, Hôpital Cochin, Service de Biologie de la Reproduction-CECOS, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH